Seres Therapeutics, Inc.
MCRB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $0 | -$114 | -$250 | -$66 |
| Dep. & Amort. | $5 | $6 | $7 | $6 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $21 | $34 | $25 | $20 |
| Change in WC | -$66 | -$59 | -$18 | $42 |
| Other Non-Cash | -$110 | $15 | $8 | $5 |
| Operating Cash Flow | -$149 | -$117 | -$229 | $7 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$8 | -$10 | -$10 |
| Net Acquisitions | $0 | $0 | -$92 | $0 |
| Inv. Purchases | $14 | -$4 | -$48 | -$96 |
| Inv. Sales/Matur. | $143 | $23 | $140 | $170 |
| Other Inv. Act. | -$14 | $0 | $92 | $0 |
| Investing Cash Flow | $142 | $11 | $82 | $64 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$128 | $51 | $26 | -$1 |
| Stock Issued | $24 | $18 | $101 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $14 | $3 | $3 | $2 |
| Financing Cash Flow | -$90 | $72 | $130 | $1 |
| Forex Effect | -$0 | $0 | -$0 | -$0 |
| Net Chg. in Cash | -$97 | -$35 | -$17 | $72 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $136 | $171 | $188 | $116 |
| End Cash | $39 | $136 | $171 | $188 |
| Free Cash Flow | -$149 | -$125 | -$239 | -$3 |